Compare CNO & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CNO | ADMA |
|---|---|---|
| Founded | 1979 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Accident &Health Insurance | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 4.1B |
| IPO Year | 1987 | N/A |
| Metric | CNO | ADMA |
|---|---|---|
| Price | $42.80 | $19.15 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $43.60 | $28.50 |
| AVG Volume (30 Days) | 651.0K | ★ 2.9M |
| Earning Date | 11-03-2025 | 11-05-2025 |
| Dividend Yield | ★ 1.65% | N/A |
| EPS Growth | 20.08 | ★ 205.35 |
| EPS | ★ 2.98 | 0.86 |
| Revenue | ★ $4,441,500,000.00 | $488,559,000.00 |
| Revenue This Year | N/A | $22.19 |
| Revenue Next Year | $3.57 | $24.33 |
| P/E Ratio | ★ $13.84 | $23.11 |
| Revenue Growth | N/A | ★ 27.63 |
| 52 Week Low | $34.63 | $13.50 |
| 52 Week High | $43.20 | $25.67 |
| Indicator | CNO | ADMA |
|---|---|---|
| Relative Strength Index (RSI) | 67.78 | 58.36 |
| Support Level | $39.81 | $19.13 |
| Resistance Level | $43.56 | $20.46 |
| Average True Range (ATR) | 0.72 | 0.72 |
| MACD | 0.23 | -0.08 |
| Stochastic Oscillator | 81.10 | 39.47 |
CNO Financial Group Inc is a holding company for a group of insurance companies that offers middle-income American consumers insurance and securities products through exclusive agents, independent producers, and direct marketing. Consumers are served through the phone, online, mail, face-to-face with agents, or sales channels. The company's operating segments include annuity, health, and life insurance product lines as well as the investment and fee revenue segments. Maximum revenue is generated from the health product line segment. Annuity premiums account for the majority of the total premiums collected. Annuity products include fixed index annuities, traditional fixed-rate annuities, and single-premium immediate annuity products.
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.